1. KD Tripathi. Drugs for Constipation and Diarrhoea. Essentials of Medical Pharmacology. Seventh edition. 2013. Page – 684.
2. Tilo Grosser, Emer Smyth and Garret A. Fitzgerald. Anti-inflammatory, Antipyretic, and analgesic agents; Pharmacotherapy of gout. Goodman & Gilman’s: The Pharmacological Basics of Therapeutics. 12 Edition. New York Mc Graw Hill Medical 2011. Page – 979.
3. Gerald G. Briggs, Roger K. Freeman. B. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 375-376.
4. Teva Pharmaceuticals USA. Mesalamine 4 gm/60 mL Rectal Enema. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on September 2009] [Accessed 29th October 2020] https://clinicaltrials.gov/ct2/show/NCT00840203
5. Altheus Therapeutics, Inc. Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects with Left-Sided Ulcerative Colitis. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on January 2014] [Accessed 29th October 2020] https://clinicaltrials.gov/ct2/show/NCT01586533
6. Raffi Karagozian and Robert Burakoff. The role of mesalamine in the treatment of ulcerative colitis. NCBI; PMC National Library of Medicine, National Institute of Health. October 2007. [Accessed 29th October 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376091/
7. Ferring A/S; Electronic Medicines Compendium (EMC); [Revised on October 2019] [Accessed 29th October 2020] https://www.medicines.org.uk/emc/files/pil.5452.pdf